Amgen (AMGN) Capital Expenditures (2009 - 2025)
Amgen (AMGN) posted Capital Expenditures of $513 million for Q2 2026, up 39.0% from $369 million a year earlier but down 27.9% from the prior quarter.
Powered by 
Analysis
Amgen (AMGN) Capital Expenditures (2009 - 2025) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Capital Expenditures at Amgen was $2.3 billion, up 63.6% year-over-year; for FY2025, it came in at $1.86 billion, up 69.5% from FY2024.
- Annual Capital Expenditures shows a five-year compound annual growth rate of 25.0% (FY2020 to FY2025).
- In prior years, Amgen's Capital Expenditures was $1.1 billion in FY2024 (-1.4%), $1.11 billion in FY2023 (+18.8%), $936 million in FY2022 (+6.4%) and $880 million in FY2021 (+44.7%).
- Quarterly Capital Expenditures has run from a low of $160 million in Q3 2022 to a high of $712 million in Q1 2026 over five years.
- On a year-over-year basis, Capital Expenditures has increased in each of the last eight quarters, with growth averaging 55.2% over the last eight quarters.
- The strongest year-over-year quarter for Capital Expenditures in the past five years was Q1 2023, with growth of 81.1%; the weakest was Q3 2022, with a decline of 33.9%.
- According to Business Quant data, Capital Expenditures for the three prior quarters was $712 million (Q1 2026), $642 million (Q4 2025) and $436 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Yr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 7.84 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 4.83 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 1.21 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 4.11 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 1.55 Bn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 2.81 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 1.86 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 563.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 2.63 Bn |
| 10 | Vertex Pharmaceuticals | 138.90 Bn | 106.64 Bn | 2.91 Bn | 437.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 1.86 Bn |
| Dec 31, 2024 | 1.10 Bn |
| Dec 31, 2023 | 1.11 Bn |
| Dec 31, 2022 | 936.00 Mn |
| Dec 31, 2021 | 880.00 Mn |
| Dec 31, 2020 | 608.00 Mn |
| Dec 31, 2019 | 618.00 Mn |
| Dec 31, 2018 | 738.00 Mn |
| Dec 31, 2017 | 664.00 Mn |
| Dec 31, 2016 | 738.00 Mn |
| Dec 31, 2015 | 594.00 Mn |
| Dec 31, 2014 | 718.00 Mn |
| Dec 31, 2013 | 693.00 Mn |
| Dec 31, 2012 | 689.00 Mn |
| Dec 31, 2011 | 567.00 Mn |
| Dec 31, 2010 | 580.00 Mn |
| Dec 31, 2009 | 530.00 Mn |
API Access
Amgen Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures-annual&ticker=AMGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures-annual", "ticker": "AMGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures-annual&ticker=AMGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();